HHS releases new HIPAA rules

The HHS Office for Civil Rights has published the final rule implementing the HITECH Act, including modifications to HIPAA regarding patient privacy. » More

B+L initiates Phase III program for glaucoma drug candidate licensed from Nicox

Bausch + Lomb has started Phase III clinical testing of latanoprostene bunod licensed by Nicox S.A. to B+L » More

iVue Normative Database receives FDA clearance

Optovue has received FDA 510(k) clearance of the Normative Database for its iVue SD-OCT system. » More

Allergan wins round in patent fight over Lumigan

Appeals court upheld a decision favoring Allergan in a patent contest against two generic drug makers over the drug Lumigan.
» More

Promising viral conjunctivitis treatment goes into Phase 2b trial

NovaBay Pharmaceuticals is conducting a global Phase 2b trial of its proprietary NVC-422, a new generation N-chlorotaurine-based molecule for treating viral conjunctivitis. » More

VEE offers new programming to help students prepare for post-grad decisions

Vision Expo East will feature new programming to help optometry students successfully make the leap from the classroom to professional practice. » More

CONNECT WITH Optometry Times

Join your colleagues in conversation, respond to hot-topic questions, and stay up to date on breaking news. Like and follow us today!

» Facebook

» Twitter